Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Cymbalta Halted By GMP Issues; “Approvable” Letter Issued Sept. 13

Sep 23 2002

• By The Pink Sheet

Related Content

Lilly Cialis Using Alternate Manufacturing Facilities For 2nd Half 2003 Launch

Jul 22 2002

Lilly Dual-Acting Cymbalta Promoted By Dual Sales Force With Quintiles Deal

Jul 29 2002

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window